An Activist Investor Just Bought $1 Billion Worth of Pfizer. Here's What It Means for the Stock
On Oct. 6, The Wall Street Journal reported that activist investor group Starboard Value owns a stake in Pfizer ( PFE -2.82%) that's worth approximately $1 billion. Now, Starboard will aim to work with the company's management as well as consult with former executives -- all with the aim of turning around Pfizer's sagging fortunes.
Pfizer’s Leadership Stability and Activist Investor Watch: A Hold Rating Analysis
Leerink Partners analyst David Risinger has maintained their neutral stance on PFE stock, giving a Hold rating on October 7. David
Ex-Pfizer Execs Backed Its Leadership. An Activist Investor Says They Were 'Threatened'
Key Takeaways Two former Pfizer executives published a statement saying they support management as it gets pressured for changes by activist investor Starboard Value.The ex-Pfizer executives, Ian Read and Frank D'Amelio,
Activist investor Starboard cries foul play in exec U-turn at Pfizer
Starboard has accused Pfizer of “coercive conduct” after executives who initially backed the hedge fund retracted their support.
Activist Investor Starboard Value Presses Pfizer's Board Amid Corporate Tensions
The ongoing corporate battle between Pfizer and activist investment firm Starboard Value escalated on Thursday when Starboard pushed Pfizers board to investigate alleged coercive actions. This follows the
Pfizer's CEO gains support of ex-execs amid activist investor talks
Former Pfizer executives who were reportedly working with activist investor Starboard Value days ago to help turnaround the pharma giant have switched sides. Former CEO Ian Read a
3 Reliable Dividend Stocks With Yields Above 5% That You Can Buy With Less Than $100 Right Now
The three-month period ended June 30 was the 18th consecutive quarter in which AT&T added over 200,000 new fiber-internet subscribers. Late last year, the company also launched a fixed-wireless ...
Why Pfizer Stock Popped Today
Pfizer ( PFE 3.46%) was a stock on the move Wednesday, and not because of any news generated by the healthcare company.
Morgan Stanley Reaffirms Their Hold Rating on Pfizer (PFE)
In a report released today, Terence Flynn from Morgan Stanley maintained a Hold rating on Pfizer (PFE – Research Report), with a price ...
These Stocks Moved the Most Today: Pfizer, Super Micro, Generac, Apple, Amazon, Arcadium Lithium, Tesla, Netflix, and More
Activist investor Starboard has taken a $1 billion stake in Pfizer, according to a report, Super Micro stock surges, and ...
Is Pfizer a Buy Right Now or a Value Trap?
On top of this, Pfizer also faces key patent expirations of certain older products, and earlier estimated this will result in ...
Pfizer: A Strong Product Pipeline Could Lead To Significant Upside
Pfizer's stock is poised for growth with strong technical and fundamental indicators, promising pipeline, and Seagen ...
Pfizer Inc. (PFE): A Buzzing AI Health Stock to Add to Your Portfolio
The economic impact of AI is projected to be substantial, particularly in regions like China and North America, which are ...
Pfizer, Vista Outdoor, Duckhorn Portfolio And Other Big Stocks Moving Higher On Monday
U.S. stocks were lower, with the Dow Jones index falling more than 100 points on Monday. Shares of Pfizer Inc PFE rose during ...
2 High-Yield Dividend Stocks That Can Deliver a Lifetime of Passive Income
Verizon's strength stems from its dominant U.S. wireless market position, controlling approximately 40% of the postpaid phone ...
2 Incredibly Cheap Big Pharma Stocks to Buy Now
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.